About the programme
During the height of the COVID-19 pandemic the Health Foundation, like many other organisations, wanted to find ways to support the UK’s health and care system facing the specific challenges presented by COVID-19. As a funder of research, we also wanted to build evidence to scrutinise the measures that were taken in response to the pandemic and the long-term consequences of COVID-19.
The COVID-19 Research Programme was launched in 2020, aiming to inform policy and service delivery decisions about the future of health and care services in response to the COVID-19 pandemic.
The programme gave funding to UK-focused projects that explored:
- how health and social care service delivery has changed in light of COVID-19
- the impact of COVID-19 on health inequalities and the wider determinants of health.
Each team received between £100,000 and £200,000. The projects were all based around highly applied research that had direct relevance to policy and practice and were run by interdisciplinary teams that combined expertise from a broad range of disciplines. Each team involved patients, the public and/or people with lived experiences within their projects.
In October 2020, we also established the COVID-19 impact inquiry. This time-limited inquiry built on our research programme, seeking to explore how people’s experiences of the pandemic were influenced by their pre-existing health and health inequalities, and the likely impact of the response to the pandemic on people’s health and health inequalities.
Programme learning
The research programme findings and the cross-cutting themes from the projects we funded as part of this programme have been summarised by Hardeep Aiden, Research Manager, 'The COVID-19 pandemic: where do we go from here?'.
The Health Foundation will continue to build on this funded research and determine where there may still be unanswered questions. In addition to this funded programme, the Foundation has supported work to establish how a long-term research agenda might create a UK more resilient to future health shocks such as COVID-19.